Coronavirus Update: US Adds To Antibody Push With $486m AstraZeneca Deal

Plus: Bharat To Start Phase III Vaccine Trials Shortly

 
• By Scrip Team
  
AstraZeneca
AstraZeneca's COVID-19 vaccine trial is still halted in the US, but the company is forging ahead with a new antibody therapy deal with the government.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip